Another company we invest in operates in a different segment of the healthcare sector, specialising in manufacturing polymers used primarily in medical devices, such as catheters.
The increasing trend towards non-invasive surgeries, which use these catheters, drives demand for its products.
Article continues after advert
Paul Daggett is a managing director at Neuberger Berman and manager of NB Private Equity Partners
Page 2 of 2
